Área salud
Vol. 6. Issue. 3. (July – September 2026)
Área salud
Clinical efficacy and safety profile of biological therapies versus standard interventions in MS and NMOSD relapses: A systematic review
Background Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSDs) are characterized by relapses that contribute to accumulating disability. Over the past decade, monoclonal antibodies have increasingly replaced standard interventions (placebo or conventional immunosuppressants) due […]
Área salud
Expanding the epidemiologic spectrum of TTR amyloidosis in Spain. A new epidemiological focus in Zamora
Objective The presence of a new epidemiological focus of Familial Amyloidotic Polyneuropathy (FAP) is reported. Methods The demographic, clinical and genetic characteristics of the study are analyzed. Results The prevalence in this new focus is […]
Área salud
Very late-onset myasthenia gravis: Clinical characteristics and prognosis at a secondary hospital
Introduction Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction. Given the increase observed in its incidence in recent decades, especially in older ages, understanding its characteristics is crucial to improving its diagnosis […]
Área salud
Frequency of area postrema syndrome in a Peruvian cohort of patients with neuromyelitis optica spectrum disorder
Background Neuromyelitis Optica Spectrum Disorder (NMOSD) is an autoimmune, inflammatory disorder of the Central Nervous System that typically involves the spinal cord, optic nerves, and area postrema. Descriptions of area postrema syndrome (APS) in Latin […]
Área salud
Post-ischemic stroke epilepsy in adults: A cross-sectional study
Introduction Cerebrovascular disease is the leading cause of epilepsy in adults. Epilepsy secondary to acute ischemic stroke (AIS) is associated with worse outcomes. The prevalence varies in different studies. Risk factors for this condition have […]